|
|
argenx SE
BRU •
Healthcare •
Biotechnology •
Quote as of 05/22/2026 17:39
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeBRU
Market Capitalization42,176 mln
Float61.98 mln
Earnings Date05/07/2026
1-Year Forecast
845
Attractive
Relative Strength
81
/ 100
Strongly outperforming
Key Fundamentals
EPS16.73
P/E41.90
ROE19.98
RPS54.70
ROIC35.66
ROA17.15
Interest Cover255
EBITDA, mln1,113
EV / EBITDA35.10
EV / EBIT35.10
Revenue, mln3,613
EV / Revenue10.81
Financial Strength
Altman Z-Score23.17
Piotroski F-Score
4
/ 9
Beneish M-Score-1.71
Price to Intrinsic Value43.65
Price to Graham Number3.61
1-Year Target Price845
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
1.13% |
52
/ 100
 |
| 1 Month |
3.33% |
69
/ 100
 |
| 2 Months |
-0.28% |
50
/ 100
|
| 6 Months |
-12.09% |
16
/ 100
 |
| 1 Year |
35.96% |
85
/ 100
 |
|
| |
